TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Tumor hypoxia and hypoxia-inducible factor 1 (HIF-1) activation are associated with cancer progression. Here, we demonstrate that the transcription factor TAp73 opposes HIF-1 activity through a nontranscriptional mechanism, thus affecting tumor angiogenesis. TAp73-deficient mice have an increased incidence of spontaneous and chemically induced tumors that also display enhanced vascularization. Mechanistically, TAp73 interacts with the regulatory subunit (α) of HIF-1 and recruits mouse double minute 2 homolog into the protein complex, thus promoting HIF-1α polyubiquitination and consequent proteasomal degradation in an oxygen-independent manner. In human lung cancer datasets, TAp73 strongly predicts good patient prognosis, and its expression is associated with low HIF-1 activation and angiogenesis. Our findings, supported by in vivo and clinical evidence, demonstrate a mechanism for oxygen-independent HIF-1 regulation, which has important implications for individualizing therapies in patients with cancer.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
AMELIO, Ivano, Satoshi INOUE, Elke K. MARKERT, Arnold J. LEVINE, Richard A. KNIGHT, Tak W. MAK, Gerry MELINO, 2015. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation. In: Proceedings of the National Academy of Sciences of the United States of America. National Academy of Sciences. 2015, 112(1), pp. 226-231. ISSN 0027-8424. eISSN 1091-6490. Available under: doi: 10.1073/pnas.1410609111BibTex
@article{Amelio2015TAp73-57078, year={2015}, doi={10.1073/pnas.1410609111}, title={TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation}, number={1}, volume={112}, issn={0027-8424}, journal={Proceedings of the National Academy of Sciences of the United States of America}, pages={226--231}, author={Amelio, Ivano and Inoue, Satoshi and Markert, Elke K. and Levine, Arnold J. and Knight, Richard A. and Mak, Tak W. and Melino, Gerry} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/57078"> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/57078"/> <dc:contributor>Markert, Elke K.</dc:contributor> <dc:creator>Inoue, Satoshi</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Mak, Tak W.</dc:creator> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/57078/1/Amelio_2-14peddrdr01sf4.pdf"/> <dc:contributor>Mak, Tak W.</dc:contributor> <dc:creator>Knight, Richard A.</dc:creator> <dc:contributor>Melino, Gerry</dc:contributor> <dcterms:issued>2015</dcterms:issued> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Markert, Elke K.</dc:creator> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:creator>Levine, Arnold J.</dc:creator> <dc:contributor>Levine, Arnold J.</dc:contributor> <dc:language>eng</dc:language> <dc:creator>Amelio, Ivano</dc:creator> <dc:rights>terms-of-use</dc:rights> <dc:contributor>Amelio, Ivano</dc:contributor> <dc:contributor>Knight, Richard A.</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-30T09:08:00Z</dc:date> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:title>TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation</dcterms:title> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/57078/1/Amelio_2-14peddrdr01sf4.pdf"/> <dc:contributor>Inoue, Satoshi</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-30T09:08:00Z</dcterms:available> <dc:creator>Melino, Gerry</dc:creator> <dcterms:abstract xml:lang="eng">Tumor hypoxia and hypoxia-inducible factor 1 (HIF-1) activation are associated with cancer progression. Here, we demonstrate that the transcription factor TAp73 opposes HIF-1 activity through a nontranscriptional mechanism, thus affecting tumor angiogenesis. TAp73-deficient mice have an increased incidence of spontaneous and chemically induced tumors that also display enhanced vascularization. Mechanistically, TAp73 interacts with the regulatory subunit (α) of HIF-1 and recruits mouse double minute 2 homolog into the protein complex, thus promoting HIF-1α polyubiquitination and consequent proteasomal degradation in an oxygen-independent manner. In human lung cancer datasets, TAp73 strongly predicts good patient prognosis, and its expression is associated with low HIF-1 activation and angiogenesis. Our findings, supported by in vivo and clinical evidence, demonstrate a mechanism for oxygen-independent HIF-1 regulation, which has important implications for individualizing therapies in patients with cancer.</dcterms:abstract> </rdf:Description> </rdf:RDF>